(Total Views: 937)
Posted On: 01/09/2021 12:40:07 PM
Post# of 148897
The heroes are the ones who took part in the leronlimab clinical trial, received the placebo and died.
Ran across this article this morning and was taken that this gentleman must have been one of the unfortunate ones to take part in the clinical trial and receive the placebo.
https://theworldlink.com/community/bandon/new...bb584.html
"the virus found its way to them, and he was diagnosed Oct. 26."
"He received two shots as part of an experimental study on leronlimab, a drug researchers think could improve immune function in severe COVID-19 patients."
"Miguel De La Torre died soon after, in the early hours of Nov. 26, at the age of 56."
During this period, October 26, to November 26, there were NO eINDs, so the shots he received had to be a part of the CD-12 clinical trial, wherein he, the doctors and the investigators were double blinded, and even to date, even after his death, no one knows whether or not he received the drug or the placebo.
But, comparing his reaction to it, to those that received the leronlimab eINDs, I was struck with the obvious conclusion that he must have been one of the unfortunate ones that received the placebo and he died a HERO. Because of him and the other 130 like him (394 CD-12 patients divided by 3 in the placebo group), hopefully leronlimab will be approved and save ten of thousands, hundreds of thousands and millions of people. Miguel you are a hero.
Ran across this article this morning and was taken that this gentleman must have been one of the unfortunate ones to take part in the clinical trial and receive the placebo.
https://theworldlink.com/community/bandon/new...bb584.html
"the virus found its way to them, and he was diagnosed Oct. 26."
"He received two shots as part of an experimental study on leronlimab, a drug researchers think could improve immune function in severe COVID-19 patients."
"Miguel De La Torre died soon after, in the early hours of Nov. 26, at the age of 56."
During this period, October 26, to November 26, there were NO eINDs, so the shots he received had to be a part of the CD-12 clinical trial, wherein he, the doctors and the investigators were double blinded, and even to date, even after his death, no one knows whether or not he received the drug or the placebo.
But, comparing his reaction to it, to those that received the leronlimab eINDs, I was struck with the obvious conclusion that he must have been one of the unfortunate ones that received the placebo and he died a HERO. Because of him and the other 130 like him (394 CD-12 patients divided by 3 in the placebo group), hopefully leronlimab will be approved and save ten of thousands, hundreds of thousands and millions of people. Miguel you are a hero.
(28)
(0)Scroll down for more posts ▼
